✦ LIBER ✦

Cetuximab, gemcitabine and capecitabine in patients with inoperable biliary tract cancer: A phase 2 study

✍ Scribed by Rubovszky, G.; Láng, I.; Ganofszky, E.; Horváth, Z.; Juhos, É.; Nagy, T.; Szabó, E.; Szentirmay, Z.; Budai, B.; Hitre, E.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Cetuximab, gemcitabine, and oxaliplatin

✍ Birgit Gruenberger; Johannes Schueller; Ute Heubrandtner; Fritz Wrba; Dietmar Ta 📂 Article 📅 2010 🏛 The Lancet 🌐 English ⚖ 180 KB

A phase II study of gemcitabine in combi

✍ Hyun Jung Kim; Nam Su Lee; Sang-Cheol Lee; Sang Byung Bae; Chan Kyu Kim; Young G 📂 Article 📅 2009 🏛 Springer 🌐 English ⚖ 347 KB

Phase II trial of gemcitabine combined w

✍ Jeeyun Lee; Tae-You Kim; Myung Ah Lee; Myung Ju Ahn; Hoon-Kyo Kim; Ho Yeong Lim; 📂 Article 📅 2007 🏛 Springer 🌐 English ⚖ 246 KB

Phase II study of single-agent gemcitabi

✍ Takuji Okusaka; Hiroshi Ishii; Akihiro Funakoshi; Kenji Yamao; Shinichi Ohkawa; 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 214 KB

191 Phase II trial of gemcitabine and ca

✍ J.J. Knox; D. Hedley; A. Oza; L. Siu; R. Feld; E. Chen; M. Nematollahi; G. Pond; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 313 KB

Docetaxel plus gemcitabine in combinatio

✍ N. Xenidis; L. Chelis; K. Amarantidis; E. Chamalidou; P. Dimopoulos; N. Courcout 📂 Article 📅 2011 🏛 Springer 🌐 English ⚖ 288 KB